Quarterly ResultAug 7, 2026, 02:36 PM
Embecta Acquires Owen Mumford; Q3 Revenue Down 8.1% to $271.7M
AI Summary
Embecta Corp. acquired Owen Mumford for an upfront cash payment of $169.9 million, expanding its medical device portfolio. For the third quarter ended June 30, 2026, the company reported a revenue decrease of 8.1% to $271.7 million and net income fell to $21.1 million from $45.5 million year-over-year. A securities class action lawsuit was filed against the company and its officers regarding fiscal year 2026 revenue guidance.
Key Highlights
- Acquired Owen Mumford for $169.9M upfront cash on May 15, 2026.
- Q3 2026 Revenue decreased 8.1% to $271.7M from $295.5M YoY.
- Q3 2026 Net Income fell to $21.1M from $45.5M YoY.
- Q3 2026 Diluted EPS was $0.36, down from $0.78 YoY.
- Nine-month 2026 Revenue decreased to $754.7M from $816.4M YoY.
- Securities class action filed alleging false FY2026 revenue guidance.
- Repurchased $8.7M of common stock for the nine months ended June 30, 2026.
- Long-term debt reduced to $1,315.7M from $1,388.7M since Sept 2025.
Price Impact
More from EMBC